top
Search terms
Results 1 - 2 of 2 - ordered by :
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Ehjournal

Abstract Aims To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and ...

European Heart Journal, Filippatos, Gerasimos, Anker, Stefan D., Böhm, Michael, Gheorghiade, Mihai, Køber, Lars, Krum, Henry, Maggioni, Aldo P., Ponikowski, Piotr, Voors, Adriaan A., Zannad, ...

Date : 14/07/2016 Item size : 336949 bytes
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Ehjournal

Abstract Aims To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and ...

European Heart Journal, Filippatos, Gerasimos, Anker, Stefan D., Böhm, Michael, Gheorghiade, Mihai, Køber, Lars, Krum, Henry, Maggioni, Aldo P., Ponikowski, Piotr, Voors, Adriaan A., Zannad, ...

Date : 14/07/2016 Item size : 387225 bytes